ResearcherStanford MedicineActive in the last 2 years
James M. Ford
Matched on ORCID iD 0000-0002-2513-7025; OpenAlex author ID A5000788791. Sources: ClinicalTrials.gov.
Their work
- Papers
- 4
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2011: 1 paper · 2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 trial · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Exploring the Melanoma and Pancreatic Cancer Phenotype of a Potential CDKN2A Founder Variant, I49T (c.146T>C; p.Ile49Thr), in Individuals of Predominantly Mexi… Co-author DOI 10.1200/po-26-00083↗
- Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. Co-author DOI 10.1016/j.ijrobp.2014.06.066↗
- Intensity-modulated radiotherapy for pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ijrobp.2011.09.035↗
- Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Co-author DOI 10.1016/j.ijrobp.2010.05.006↗
Trials 1
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daisy Naranjo Hernández · 1 shared paper, 2026 · strength 0.22
- Charite Nicolette Ricker · 1 shared paper, 2026 · strength 0.22
- Albert C. Koong · 3 shared papers, 2011–2014 · strength 0.08
- Paper Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. DOI 10.1016/j.ijrobp.2014.06.066↗
- Paper Intensity-modulated radiotherapy for pancreatic adenocarcinoma. DOI 10.1016/j.ijrobp.2011.09.035↗
- Paper Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pa… DOI 10.1016/j.ijrobp.2010.05.006↗
- Pamela L. Kunz · 3 shared papers, 2011–2014 · strength 0.08
- Paper Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. DOI 10.1016/j.ijrobp.2014.06.066↗
- Paper Intensity-modulated radiotherapy for pancreatic adenocarcinoma. DOI 10.1016/j.ijrobp.2011.09.035↗
- Paper Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pa… DOI 10.1016/j.ijrobp.2010.05.006↗
- Jeffrey Allen Norton · 3 shared papers, 2011–2014 · strength 0.08
- Paper Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. DOI 10.1016/j.ijrobp.2014.06.066↗
- Paper Intensity-modulated radiotherapy for pancreatic adenocarcinoma. DOI 10.1016/j.ijrobp.2011.09.035↗
- Paper Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pa… DOI 10.1016/j.ijrobp.2010.05.006↗
- Daniel Tandel Chang · 3 shared papers, 2011–2014 · strength 0.08
- Paper Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. DOI 10.1016/j.ijrobp.2014.06.066↗
- Paper Intensity-modulated radiotherapy for pancreatic adenocarcinoma. DOI 10.1016/j.ijrobp.2011.09.035↗
- Paper Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pa… DOI 10.1016/j.ijrobp.2010.05.006↗
- George Albert Fisher · 3 shared papers, 2011–2014 · strength 0.08
- Paper Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. DOI 10.1016/j.ijrobp.2014.06.066↗
- Paper Intensity-modulated radiotherapy for pancreatic adenocarcinoma. DOI 10.1016/j.ijrobp.2011.09.035↗
- Paper Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pa… DOI 10.1016/j.ijrobp.2010.05.006↗
- George A. Poultsides · 2 shared papers, 2012–2014 · strength 0.06
- Brendan Christopher Visser · 2 shared papers, 2012–2014 · strength 0.06
- Aya Kamaya · 1 shared paper, 2014 · strength 0.04
- Erqi Liu Pollom · 1 shared paper, 2014 · strength 0.04
- Muthuraman Alagappan · 1 shared paper, 2014 · strength 0.04
- J.A. Abelson · 1 shared paper, 2012 · strength 0.03
- James Don Murphy · 1 shared paper, 2012 · strength 0.03
- Karyn A. Goodman · 1 shared paper, 2011 · strength 0.02
- Devin D. Schellenberg · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.